PRDX2 and cancer: CLT exerts its antitumor effect in various ways, including increasing reactive oxygen species (ROS) levels and causing ROS-dependent endoplasmic reticulum (ER) stress, mitochondrial dysfunction, and apoptosis by inhibiting peroxiredoxin-2 (PRDX2, an antioxidant enzyme in cancer cells) [8].